The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

30 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria.EBI
Case Western Reserve University
Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11).EBI
Case Western Reserve University
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.EBI
Case Western Reserve University
In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds.EBI
Case Western Reserve University
Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators.EBI
Case Western Reserve University
Dibenzothiazoles as novel amyloid-imaging agents.EBI
Case Western Reserve University
Modification of the enkephalin"message" with an artificial polycationic C-terminus.EBI
Case Western Reserve University
Structure-Guided Synthesis and Mechanistic Studies Reveal Sweetspots on Naphthyl Salicyl Hydrazone Scaffold as Non-Nucleosidic Competitive, Reversible Inhibitors of Human Ribonucleotide Reductase.EBI
Case Western Reserve University
Compounds for Disease TreatmentBDB
Duke University
HSD17B13 INHIBITORS AND USES THEREOFBDB
Fl2022-001
GSK-3 inhibitorsBDB
Bristol-Myers Squibb
Pharmaceutical composition for treating FLT3 mutation-positive cancer, mutant FLT3 inhibitor and uses thereofBDB
Fujifilm
Benzimidazol-2-amines as MIDH1 inhibitorsBDB
Bayer Pharma Aktiengesellschaft
Tetrahydro-pyrimidoazepines as modulators of TRPV1BDB
Janssen Pharmaceutica
Isonicotinohydrazones as inhibitors of alkaline phosphatase and ecto-5'-nucleotidase.BDB
Quaid-I-Azam University
Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1BDB
Novartis
Macrolides and their useBDB
Basilea Pharmaceutica
Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of useBDB
F. Hoffmann-La Roche
Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine.BDB
Georgetown University
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase.BDB
The Scripps Research Institute
Identification of RIP1 kinase as a specific cellular target of necrostatins.BDB
Tufts University
Correlating solution binding and ESI-MS stabilities by incorporating solvation effects in a confined cucurbit[8]uril system.BDB
University of Cambridge
Thermodynamics of the molecular and chiral recognition of cycloalkanols and camphor by modified beta-cyclodextrins possessing simple aromatic tethers.BDB
Nankai University
Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.BDB
Ono Pharmaceutical
3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3.BDB
Wyeth Research
Rhodanine derivatives as selective protease inhibitors against bacterial toxins.BDB
Burnham Institute For Medical Research